Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301244549> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4301244549 endingPage "68" @default.
- W4301244549 startingPage "62" @default.
- W4301244549 abstract "Aim of the study: to study antihypertensive and organ-protective efficacy of indapamide and valsartan combined therapy hypertensive patients with high cardiovascular risk and metabolic disorders. Methods: The studyincluded 37 patients with stage I-III hypertension (ESH 2007), with an average age of 47.67±10.02 years, 48.6% men and 51.4% woman. Blood pressure was measured by Korotkov method. All patients were performed by M- and B-mode echocardiography. Flow-mediated endothelium dependent vasodilatation was measured during reactive hyperaemia due to 5 minute brachial occlusion.A 7.5 MHz highresolution ultrasound was used to measure carotid artery intimaemedia thickness (IMT). Blood lipid and glucose level, serum creatinin and uric acid level were estimated by enzyme assay method on biochemical analyzer “Daytona TM”. Results: 12-weekly combined therapy with indapamide and valsartan were shown very good antihypertensive efficacy in average daily doses 2.5 mg and 80±40.6 mg respectively, with reducing average blood pressure on 19.7±7.0% and attained goal level of BP in 92% cases. During the treatment were found significantly regress of left ventricular hypertrophy by reducing left ventricular mass index on 16.2±11.3%, effective vasoprotection, without significantly changes of metabolic disorders, which characterized indapamide and valsartan combination like metabolic neutral drug combination. Conclusion: Indapamide and valsartan combined therapy characterize with high antihypertensive, cardio- and vasoprotective efficacy andmetabolic neutrality choosing for treatment hypertensive patients with high cardiovascular risk and metabolic disorders." @default.
- W4301244549 created "2022-10-05" @default.
- W4301244549 creator A5034496361 @default.
- W4301244549 creator A5051840547 @default.
- W4301244549 creator A5054997897 @default.
- W4301244549 creator A5056254065 @default.
- W4301244549 creator A5057128373 @default.
- W4301244549 date "2014-12-30" @default.
- W4301244549 modified "2023-10-01" @default.
- W4301244549 title "IEFFICACY OF INDAPAMIDE AND VALSARTAN COMBINED THERAPY PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC DISORDERS" @default.
- W4301244549 cites W140325393 @default.
- W4301244549 cites W1963558586 @default.
- W4301244549 cites W1993410366 @default.
- W4301244549 cites W1995934832 @default.
- W4301244549 cites W2013747044 @default.
- W4301244549 cites W2020608625 @default.
- W4301244549 cites W2054521115 @default.
- W4301244549 cites W2056893352 @default.
- W4301244549 cites W2145330333 @default.
- W4301244549 cites W2152178651 @default.
- W4301244549 cites W2160654062 @default.
- W4301244549 cites W2168907840 @default.
- W4301244549 cites W2172032309 @default.
- W4301244549 cites W2311663622 @default.
- W4301244549 cites W23664147 @default.
- W4301244549 doi "https://doi.org/10.38109/2225-1685-2014-4-62-68" @default.
- W4301244549 hasPublicationYear "2014" @default.
- W4301244549 type Work @default.
- W4301244549 citedByCount "0" @default.
- W4301244549 crossrefType "journal-article" @default.
- W4301244549 hasAuthorship W4301244549A5034496361 @default.
- W4301244549 hasAuthorship W4301244549A5051840547 @default.
- W4301244549 hasAuthorship W4301244549A5054997897 @default.
- W4301244549 hasAuthorship W4301244549A5056254065 @default.
- W4301244549 hasAuthorship W4301244549A5057128373 @default.
- W4301244549 hasBestOaLocation W43012445491 @default.
- W4301244549 hasConcept C126322002 @default.
- W4301244549 hasConcept C134018914 @default.
- W4301244549 hasConcept C158846371 @default.
- W4301244549 hasConcept C164705383 @default.
- W4301244549 hasConcept C2776002628 @default.
- W4301244549 hasConcept C2777097880 @default.
- W4301244549 hasConcept C2777387769 @default.
- W4301244549 hasConcept C2777691872 @default.
- W4301244549 hasConcept C2777748223 @default.
- W4301244549 hasConcept C2779646130 @default.
- W4301244549 hasConcept C71924100 @default.
- W4301244549 hasConcept C84393581 @default.
- W4301244549 hasConceptScore W4301244549C126322002 @default.
- W4301244549 hasConceptScore W4301244549C134018914 @default.
- W4301244549 hasConceptScore W4301244549C158846371 @default.
- W4301244549 hasConceptScore W4301244549C164705383 @default.
- W4301244549 hasConceptScore W4301244549C2776002628 @default.
- W4301244549 hasConceptScore W4301244549C2777097880 @default.
- W4301244549 hasConceptScore W4301244549C2777387769 @default.
- W4301244549 hasConceptScore W4301244549C2777691872 @default.
- W4301244549 hasConceptScore W4301244549C2777748223 @default.
- W4301244549 hasConceptScore W4301244549C2779646130 @default.
- W4301244549 hasConceptScore W4301244549C71924100 @default.
- W4301244549 hasConceptScore W4301244549C84393581 @default.
- W4301244549 hasIssue "4" @default.
- W4301244549 hasLocation W43012445491 @default.
- W4301244549 hasLocation W43012445492 @default.
- W4301244549 hasOpenAccess W4301244549 @default.
- W4301244549 hasPrimaryLocation W43012445491 @default.
- W4301244549 hasRelatedWork W2099184338 @default.
- W4301244549 hasRelatedWork W2347252065 @default.
- W4301244549 hasRelatedWork W2349802271 @default.
- W4301244549 hasRelatedWork W2350935958 @default.
- W4301244549 hasRelatedWork W2355803572 @default.
- W4301244549 hasRelatedWork W2379638639 @default.
- W4301244549 hasRelatedWork W2381394904 @default.
- W4301244549 hasRelatedWork W2738906127 @default.
- W4301244549 hasRelatedWork W2807681063 @default.
- W4301244549 hasRelatedWork W4301244549 @default.
- W4301244549 isParatext "false" @default.
- W4301244549 isRetracted "false" @default.
- W4301244549 workType "article" @default.